MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 49 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $37 | -7.5% | 79 | 0.0% | 0.00% | – |
| Q4 2022 | $40 | -99.9% | 79 | +216.0% | 0.00% | – |
| Q4 2020 | $34,000 | +78.9% | 25 | 0.0% | 0.00% | – |
| Q3 2020 | $19,000 | 0.0% | 25 | 0.0% | 0.00% | – |
| Q2 2020 | $19,000 | +26.7% | 25 | 0.0% | 0.00% | – |
| Q1 2020 | $15,000 | -73.7% | 25 | 0.0% | 0.00% | – |
| Q4 2019 | $57,000 | +235.3% | 25 | -7.4% | 0.00% | – |
| Q3 2019 | $17,000 | -26.1% | 27 | 0.0% | 0.00% | – |
| Q2 2019 | $23,000 | -14.8% | 27 | +8.0% | 0.00% | – |
| Q1 2019 | $27,000 | -99.1% | 25 | -99.5% | 0.00% | – |
| Q4 2018 | $2,851,000 | -35.3% | 4,792 | 0.0% | 0.00% | – |
| Q3 2018 | $4,409,000 | +112.1% | 4,792 | 0.0% | 0.00% | – |
| Q2 2018 | $2,079,000 | -86.5% | 4,792 | -76.2% | 0.00% | – |
| Q1 2018 | $15,393,000 | -20.2% | 20,127 | +21.1% | 0.00% | – |
| Q4 2017 | $19,282,000 | +183.6% | 16,622 | +222.7% | 0.00% | – |
| Q3 2017 | $6,799,000 | -27.3% | 5,151 | -6.9% | 0.00% | – |
| Q2 2017 | $9,351,000 | – | 5,533 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 10,188,312 | $11,105,000 | 1.28% |
| Stonepine Capital Management, LLC | 2,008,006 | $2,189,000 | 1.26% |
| CVI Holdings, LLC | 909,625 | $991,000 | 0.94% |
| Vivo Capital, LLC | 6,818,181 | $7,432,000 | 0.74% |
| Broadfin Capital, LLC | 2,727,272 | $2,973,000 | 0.61% |
| Telemetry Investments, L.L.C. | 650,000 | $708,000 | 0.36% |
| Granite Point Capital Management, L.P. | 1,706,134 | $1,860,000 | 0.18% |
| J. Goldman & Co LP | 1,045,000 | $1,139,000 | 0.06% |
| Tibra Equities Europe Ltd | 241,966 | $264,000 | 0.03% |
| IPG Investment Advisors LLC | 42,500 | $46,325,000 | 0.02% |